RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|27 Jul 2018||Submitted||Original manuscript|
|21 Aug 2018||Reviewed||Reviewer Report - Susan Dutton|
|17 Sep 2018||Author responded||Author comments - Sean Lim|
|Resubmission - Version 2|
|17 Sep 2018||Submitted||Manuscript version 2|
|16 Oct 2018||Editorially accepted|
|9 Nov 2018||Article published||10.1186/s13063-018-2996-6|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.